EP Patent

EP3461484B9 — Dimesylate salts of 4-(3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl, their combinations with prostaglandins and the use thereof in the treatment of ocular disorders

Assigned to Alcon Inc · Expires 2021-06-09 · 5y expired

What this patent protects

Patent listed against Xalatan.

Drugs covered by this patent

Patent Metadata

Patent number
EP3461484B9
Jurisdiction
EP
Classification
—
Expires
2021-06-09
Drug substance claim
No
Drug product claim
No
Assignee
Alcon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.